Skip to main content
SpringerLink
Log in

Glutathione S-transferase T1 and M1 null genotypes and Parkinson’s disease risk: evidence from an updated meta-analysis

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Glutathione S-transferase T1 and M1 (GSTT1 and GSTM1) have been reported to be associated with Parkinson’s disease (PD). However, the results of these previous studies were inconsistent. The reported studies were conducted from 1990 to 2014 by searching PubMed. The total Odds Ratio and 95 % Confidence Interval were calculated and analyzed by Review Manager 5.1 and STATA 12. We also did subgroup analysis of ethnicity, publication year and sample size of total cases. Sensitivity analysis and publication bias were also done to evaluate the credibility of the results. A total of 3753 PD patients and 5636 controls from 19 case–control studies were identified. Overall, no association was observed (OR 1.01, 95 % CI 0.99–1.21, P = 0.07) between GSTM1 null genotype and PD. There was significant association in Caucasians when subgroup analysis of ethnicity was performed, and the same conclusion was observed in European and UK. And it was also in publication year of 1995–1999 and in sample size of total cases of <90 and 91–181. However, there was no significant association between GSTT1 null genotype and PD risk in this meta-analysis. Publication bias was negligible and the overall results were stable by sensitivity analysis. A slight increase of PD risk was detected in the meta-analysis of GSTM1 null genotype in subgroup analysis of ethnicity, publication year and sample size of total cases. However, short of statistical significance was detected for GSTT1 null genotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Dennis JC, Daniel KC (2004) Genetics and Parkinson’s disease. J Clin Neurosci 11:119–123

    Article  Google Scholar 

  2. Pinhel MA, Sado CL, Longo Gdos S, Gregório ML, Amorim GS, Florim GM et al (2013) Nullity of GSTT1/GSTM1 related to pesticides is associated with Parkinson’s disease. Arq Neuropsiquiatr 71:527–532

    Article  PubMed  Google Scholar 

  3. Wahner AD, Glatt CE, Bronstein JM, Ritz B (2007) Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson’s disease. Neurosci Lett 413:274–278

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Cornetta T, Patrono C, Terrenato I, De Nigris F, Bentivoglio AR, Testa A et al (2013) Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione S-transferase and DNA repair gene polymorphisms. Cell Mol Neurobiol 33:673–680

    Article  CAS  PubMed  Google Scholar 

  5. Stroombergen MC, Waring RH (1999) Determination of GST mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 18:141–145

    Article  CAS  PubMed  Google Scholar 

  6. De Palma G, Mozzoni P, Mutti A, Calzetti S, Negrotti A (1998) Case-control study of interactions between genetic and environmental factors in Parkinson’s disease. Lancet 352:1986–1987

    Article  PubMed  Google Scholar 

  7. Perez-Pastene C, Graumann R, Diaz-Grez F, Miranda M, Venegas P, Godoy OT et al (2007) Association of GST M1 null polymorphism with Parkinson’s disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett 418:181–185

    Article  CAS  PubMed  Google Scholar 

  8. Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K et al (2010) GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population. Parkinsonism Relat Disord 16:447–452

    Article  CAS  PubMed  Google Scholar 

  9. Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T et al (2003) Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson’s disease. Neurosci Lett 337:5–8

    Article  CAS  PubMed  Google Scholar 

  10. Jenner P, Olanow CW (1998) Understanding cell death in Parkinson’s disease. Ann Neurol 44:S72–S84

    Article  CAS  PubMed  Google Scholar 

  11. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649–671

    Article  CAS  PubMed  Google Scholar 

  12. Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904–4911

    Article  CAS  PubMed  Google Scholar 

  13. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B (1997) Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 324:25–28

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300(Pt 1):271–276

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M et al (2012) Genetic modification of the association of paraquat and Parkinson’s disease. Mov Disord 27:1652–1658

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. De Palma G, Dick FD, Calzetti S, Scott NW, Prescott GJ, Osborne A et al (2010) A case-control study of Parkinson’s disease and tobacco use: gene-tobacco interactions. Mov Disord 25:912–919

    Article  PubMed  Google Scholar 

  17. Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D (2008) Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 312:131–138

    Article  CAS  PubMed  Google Scholar 

  18. Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ et al (2007) Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study. Occup Environ Med 64:673–680

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T (2000) Variability and validity of polymorphism association studies in Parkinson’s disease. Neurology 55:533–538

    Article  CAS  PubMed  Google Scholar 

  20. Rahbar A, Kempkes M, Müller T, Reich S, Welter FL, Meves S et al (2000) Glutathione S-transferase polymorphism in Parkinson’s disease. J Neural Transm 107:331–334

    Article  CAS  PubMed  Google Scholar 

  21. Ahmadi A, Fredrikson M, Jerregârd H, Akerbäck A, Fall PA, Rannug A et al (2000) GSTM1 and mEPHX polymorphisms in Parkinson’s disease and age of onset. Biochem Biophys Res Commun 269:676–680

    Article  CAS  PubMed  Google Scholar 

  22. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG (1998) Parkinson’s disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344–1346

    Article  CAS  PubMed  Google Scholar 

  23. Vilar R, Coelho H, Rodrigues E, Gama MJ, Rivera I, Taioli E et al (2007) Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson’s disease. Eur J Neurol 14:156–161

    Article  CAS  PubMed  Google Scholar 

  24. Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD (2004) Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson’s disease. Neurosci Lett 366:326–331

    Article  CAS  PubMed  Google Scholar 

  25. Harada S, Fujii C, Hayashi A, Ohkoshi N (2001) An association between idiopathic Parkinson’s disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 288:887–892

    Article  CAS  PubMed  Google Scholar 

  26. Nicholl DJ, Bennett P, Hiller L, Bonifati V, Vanacore N, Fabbrini G et al (1999) A study of five candidate genes in Parkinson’s disease and related neurodegenerative disorders. Neurology 53:1415–1421

    Article  CAS  PubMed  Google Scholar 

  27. Stroombergen MC, Waring RH, Bennett P, Williams AC (1996) Determination of the GSTM1 gene deletion frequency in Parkinson’s disease by allele specific PCR. Parkinsonism Relat Disord 2:151–154

    Article  CAS  PubMed  Google Scholar 

  28. Biswas A, Sadhukhan T, Bose K, Ghosh P, Giri AK, Das SK et al (2012) Role of glutathione S-transferase T1, M1 and P1 polymorphisms in Indian Parkinson’s disease patients. Parkinsonism Relat Disord 18:664–665

    Article  PubMed  Google Scholar 

  29. Tison F, Coutelle C, Henry P, Cassaigne A (1994) Glutathione S-transferase (class mu) phenotype in Parkinson’s disease. Mov Disord 9:117–118

    Article  CAS  PubMed  Google Scholar 

  30. Liu HZ, Peng J, Zheng F, Wang CH, Han MJ (2013) Lack of assocation of glutathione S-transferase T1 gene null and susceptibility to lung cancer in china: a meta-analysis. Asian Pac J Cancer Prev 14(12):7215–7219

    Article  PubMed  Google Scholar 

  31. Peng J, Liu HZ, Zhu YJ (2014) Null Glutathione S-transferase T1 and M1 genotypes and oral cancer susceptibility in China and India—a meta-analysis. Asian Pac J Cancer Prev 15(1):287–290

    Article  PubMed  Google Scholar 

  32. Liu HZ, Peng J, Peng CY, Ming Y, Zheng F (2014) Glutathione S-transferase M1 null genotype and hepatocellular carcinoma susceptibility in China and India: evidence from an updated meta-analysis. Asian Pac J Cancer Prev 15(12):4851–4856

    Article  PubMed  Google Scholar 

  33. Wang TF, Wang B (2014) Association between glutathione S-transferase M1/glutathione S-transferase T1 polymorphisms and Parkinson’s disease: a meta-analysis. J Neurol Sci 338(12):65–70

    Article  CAS  PubMed  Google Scholar 

  34. Nelson HH, Wiencke JK, Christiani DC et al (1995) Ethnic differene in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16:1243–1245

    Article  CAS  PubMed  Google Scholar 

  35. Yuan T, Zhou Q, Zhu W, Guo Z, Li P, Wang Y et al (2005) Relationship between genetic polymorphism of GSTTI gene and inherent susceptibility to lung cancer in Han population in Sichuan, China. Chin J Lung Cancer 8:107–111

    Article  CAS  Google Scholar 

  36. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA (1998) Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275–280

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that they have no conflict of interest.

Author information

Author notes

    Authors and Affiliations

    1. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, 430071, People’s Republic of China

      Hongzhou Liu, Jiajia Gao & Fang Zheng

    2. Department of Stomatology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, People’s Republic of China

      Jie Peng & Chaorong Tie

    3. Department of Stomatology, Wuhan Women and Children Medical Care Center, Wuhan, 430071, People’s Republic of China

      Jie Peng

    Authors
    1. Hongzhou Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Jie Peng
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Jiajia Gao
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Fang Zheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Chaorong Tie
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Chaorong Tie.

    Additional information

    H. Liu and J. Peng contributed equally to this paper.

    J. Peng is currently working at Wuhan Women and Children Medical Care Center.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    Supplementary material 1 (DOC 67 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Liu, H., Peng, J., Gao, J. et al. Glutathione S-transferase T1 and M1 null genotypes and Parkinson’s disease risk: evidence from an updated meta-analysis. Neurol Sci 36, 1559–1565 (2015). https://doi.org/10.1007/s10072-015-2159-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10072-015-2159-4

    Keywords

    Search

    Navigation